Cellnovo Group SA

Dexcom Inc. has gained a new diabetes management platform with the acquisition of TypeZero Technologies, a developer of algorithms that orchestrate insulin dosing with blood glucose monitoring data i

Used in a wide range of applications, infusion pumps are a staple in a hospital's inventory but these devices are also used in increasingly varied settings such as ambulatory centers, physician office

While clearly lagging behind their US counterparts, European biotechnology companies and medtech firms across all stages of development can still attract significant venture capital if they are innova

The global diabetes management devices market is expected to grow from $9bn in 2015 to $11.2bn by 2020, a CAGR of 4.5%. While blood glucose monitors – continuous or otherwise –account for the largest